Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials

@article{Srensen2003TreatmentOM,
  title={Treatment of multiple sclerosis with
intravenous immunoglobulin: review of clinical
trials},
  author={P. S. S{\o}rensen},
  journal={Neurological Sciences},
  year={2003},
  volume={24},
  pages={s227-s230}
}
  • P. S. Sørensen
  • Published in Neurological Sciences 2003
  • Medicine
  • Abstract.Intravenous immunoglobulin (IVIG) is an established therapy for a number of neuroimmune disorders, including Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. IVIG exerts a number of effects that may be beneficial in multiple sclerosis (MS): reduction of inflammation, inhibition of macrophages, and promotion of remyelination. Four double-blind trials have been performed of IVIG in relapsing-remitting MS. A meta-analysis of the four trials has shown that… CONTINUE READING

    Create an AI-powered research feed to stay up to date with new papers like this posted to ArXiv

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 10 CITATIONS

    Update on the use of immunoglobulin in human disease: A review of evidence

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 21 REFERENCES

    The role of intravenous immunoglobulin in the treatment of multiple sclerosis

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL